This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Case for Iprindole and Mianserin

Athanasios P. Zis, MD, FRCP(C); Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1979;36(10):1097-1107.

Abstract
• The introduction of two tricyclic compounds (iprindole and mianserin) that are reported to have antidepressant properties but to be relatively devoid of effects on central amine neurotransmitter systems has raised questions about the amine hypothesis of depression and about the mechanism of action of tricyclics in general. In view of the importance of these questions, a critical review of both the clinical and pharmacological profiles of iprindole and mianserin was undertaken. Iprindole is a relatively weak inhibitor of both norepinephrine (NE) and serotonin, whereas mianserin possesses at least modest potency as an inhibitor of NE uptake. However, the evidence is as yet insufficient to prove the superiority of iprindole over placebo in the treatment of those depressions characterized by endogenous symptoms. In considering the pharmacological profiles of these two drugs together with their clinical profiles, the data are not inconsistent with the hypothesized role of biogenic amines in major depression.

Author Affiliations
From the Clinical Psychobiology Branch, National Institute of Mental Health, Bethesda, Md.

Footnotes
Accepted for publication Nov 14, 1978.

Reprint requests to Clinical Psychobiology Branch, National Institute of Mental Health, 9000 Rockville Pike, Bldg 10, Room 4S239, Bethesda, MD 20014 (Dr Zis).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Different synaptic location of mianserin and imipramine binding sites
Brunello et al.
Science 1982;215:1112-1115.
ABSTRACT  

Depressed Patients Have Decreased Binding of Tritiated Imipramine to Platelet Serotonin 'Transporter'
Paul et al.
Arch Gen Psychiatry 1981;38:1315-1317.
ABSTRACT  

Platelet {alpha}2-Adrenergic Receptors in Major Depressive Disorder: Binding of Tritiated Clonidine Before and After Tricyclic Antidepressant Drug Treatment
Garcia-Sevilla et al.
Arch Gen Psychiatry 1981;38:1327-1333.
ABSTRACT  

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression
Charney et al.
Arch Gen Psychiatry 1981;38:1160-1180.
ABSTRACT  

Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
Peroutka and Snyder
Science 1980;210:88-90.
ABSTRACT